Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, $0.001 par value per share · CUSIP: 252828108
Event date: 2025-09-30
- Filing-level shares
- 1,315,892
- Percent of class
- 3.1%
- BCLS Fund III Investments, LP
Shares: 1,315,892 · Class: 3.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-283109
- Form type
- SCHEDULE 13G/A
- Filer
- BCLS Fund III Investments, LP
- CIK
- CIK 1952107
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership